Related references
Note: Only part of the references are listed.Glucocorticoids, bone and energy metabolism
Mark S. Cooper et al.
BONE (2016)
An Enantioselective Synthesis of an 11-β-HSD-1 Inhibitor via an Asymmetric Methallylation Catalyzed by (S)-3,3′-F2-BINOL
Yongda Zhang et al.
JOURNAL OF ORGANIC CHEMISTRY (2016)
Sequential C-H Arylation and Enantioselective Hydrogenation Enables Ideal Asymmetric Entry to the Indenopiperidine Core of an 11β-HSD-1 Inhibitor
Xudong Wei et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
Pharmacological characterization of the selective 11β-hydroxysteroid dehydrogenase 1 inhibitor, BI 135585, a clinical candidate for the treatment of type 2 diabetes
Bradford S. Hamilton et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
11β-HSD1 Inhibitors for the Treatment of Type 2 Diabetes and Cardiovascular Disease
Anna Anderson et al.
DRUGS (2013)
Structure-Based Design and Synthesis of 1,3-Oxazinan-2-one Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1
Zhenrong Xu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors as Promising Therapeutic Drugs for Diabetes: Status and Development
R. Ge et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Obesity and corticosteroids: 11β-Hydroxysteroid type 1 as a cause and therapeutic target in metabolic disease
Nicholas Michael Morton
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
11-Beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) inhibitors in Type 2 diabetes mellitus and obesity
Katherine A. Hughes et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Inhibition of 11B-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target
Malgorzata Wamil et al.
DRUG DISCOVERY TODAY (2007)
Cortisol - cause and cure for metabolic syndrome?
B. R. Walker
DIABETIC MEDICINE (2006)
Synthesis, crystal structure determination and antiproliferative evaluation of novel benzazoyl benzamides
Kristina Starcevic et al.
HETEROCYCLES (2006)
Inhibition of 11β-hydroxysteroid dehydrogenase type 1 in obesity
DJ Wake et al.
ENDOCRINE (2006)
11β-hydroxysteroid dehydrogenase type 1 as a modulator of glucocorticoid action:: from metabolism to memory
JR Seckl et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2004)
11 beta-hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes
TM Stulnig et al.
DIABETOLOGIA (2004)
Share Paper
